loading...

Sheehan Disability Scale (SDS)

Sheehan DV

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 1981

Authors

Sheehan DV

Copyright
© Copyright 1983, 2010, 2012 David V. Sheehan. All rights reserved.
Objective
To assess functional disability in work, social, and family life
Therapeutic area
  • Mental Disorders
Therapeutic indication

Generic for Mental Disorders

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Sheehan DV. The Sheehan Disability Scales. In The Anxiety Disease and How to Overcome It. New York: Charles Scribner and Sons, 1983, p. 151

Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:89-95. Review (PubMed abstract)

Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale (SDS). International Journal of Psychiatry in Medicine 1997;27(2):93-105 (PubMed abstract)

Sheehan KH, Sheehan DV. Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol. 2008 Mar;23(2):70-83 (PubMed abstract)

Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol. 2011 Mar;26(2):75-83. (PubMed abstract)

Access this questionnaire

Licensing

1. Paper/PDF versions

Any use of the paper/PDF versions of Dr David Sheehan's instruments must first be licensed by Dr David Sheehan.
A License Agreement must be signed beforehand by all users with Dr Sheehan and fees may be requested.
The original English versions of Dr David Sheehan's instruments are distributed exclusively by Dr Sheehan.

To speed up the licensing process with Dr Sheehan, all users are strongly advised to:

-          First go to Dr David Sheehan’s website (www.davidvsheehan.org), click on the relevant COA needed, click on “License Agreements for Use of COA”, and download the appropriate COA license agreement template as well as any other documents detailing the instructions to properly complete the license agreement.

-          N.B.: there are two types of license agreement: A license for the “Paper / PDF Version for Use in a Research Study or in a Healthcare Setting”, and a license for “exceptions that are granted a “no charge” license fee”.

-          Complete the appropriate license agreement and forward it to Dr David Sheehan (davidvsheehan@gmail.com).

-          Please note that partially completed licenses or licenses completed without following the instructions will either be rejected or not handled in priority by Dr Sheehan.

2. Computerized versions
 
Neither Dr David Sheehan nor Mapi Research Trust manage any computerized versions of the COA.

Distribution of Paper/PDF translations

Existing Paper/PDF translations can be obtained from Mapi Research Trust after license agreement has been signed with Dr David Sheehan.

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Fees may apply to your project.


Contact and conditions of use

Authors

Sheehan DV

Distinguished University Health Professor Emeritus
University of South Florida College of Medicine
Tampa, FL
USA
E-mail: davidvsheehan@gmail.com

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Licensing

1. Paper/PDF versions

Any use of the paper/PDF versions of Dr David Sheehan's instruments must first be licensed by Dr David Sheehan.
A License Agreement must be signed beforehand by all users with Dr Sheehan and fees may be requested.
The original English versions of Dr David Sheehan's instruments are distributed exclusively by Dr Sheehan.

To speed up the licensing process with Dr Sheehan, all users are strongly advised to:

-          First go to Dr David Sheehan’s website (www.davidvsheehan.org), click on the relevant COA needed, click on “License Agreements for Use of COA”, and download the appropriate COA license agreement template as well as any other documents detailing the instructions to properly complete the license agreement.

-          N.B.: there are two types of license agreement: A license for the “Paper / PDF Version for Use in a Research Study or in a Healthcare Setting”, and a license for “exceptions that are granted a “no charge” license fee”.

-          Complete the appropriate license agreement and forward it to Dr David Sheehan (davidvsheehan@gmail.com).

-          Please note that partially completed licenses or licenses completed without following the instructions will either be rejected or not handled in priority by Dr Sheehan.

2. Computerized versions
 
Neither Dr David Sheehan nor Mapi Research Trust manage any computerized versions of the COA.

Distribution of Paper/PDF translations

Existing Paper/PDF translations can be obtained from Mapi Research Trust after license agreement has been signed with Dr David Sheehan.

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Fees may apply to your project.

Author Website(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

  • SDS in English for the USA available here

Languages

Original language(s)

  • English for the USA

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

SDS (v3.0)

Afrikaans for South Africa*
Arabic for Israel*
Bulgarian for Bulgaria*
Cebuano for the Philippines*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for Malaysia*
English for South Africa*
English for the UK*
Estonian for Estonia*
Filipino for the Philippines*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
French for Switzerland*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Hebrew for Israel*
Hiligaynon for the Philippines*
Hungarian for Hungary*
Indonesian for Indonesia*
Italian for Italy*
Italian for Switzerland*
Japanese for Japan*
Korean for Korea*
Lithuanian for Lithuania*
Malay for Malaysia*
Mandarin for China*
Mandarin for Malaysia*
Mandarin for Taiwan*
Norwegian for Norway* L
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Estonia*
Russian for Israel*
Russian for Lithuania*
Russian for Russia*
Russian for Ukraine*
Serbian for Serbia*
Slovak for Slovakia*
Spanish for Argentina*
Spanish for Colombia*
Spanish for Mexico*
Spanish for Puerto Rico*
Spanish for Spain*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Tamil for Malaysia*
Thai for Thailand*
Turkish for Turkey*
Ukrainian for Ukraine*
* Performed by Mapi/ICON
L Has undergone a Linguistic Validation methodology

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

1. Paper/PDF versions

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services.

The author has selected Mapi/ICON Languages Services as exclusive validation company to ensure the production of harmonized and consistent paper/PDF language versions.

2. Computerized versions

Neither Dr David Sheehan nor Mapi Research Trust manage any computerized versions of the COA.

Academic Translation:

Not authorized

More information on translations

Bibliographic references of the translations:

Chinese:
Zeljic K, Zhang Y, Qiu X, Chen X, Gong H, Jin H, Zhang C, Storch EA. An Evaluation of the Psychometric Properties of the Sheehan Disability Scale in a Chinese Psychotherapy-Seeking Sample. J Cogn Psychother. 2020 Jan 1;34(1):58-69 (PubMed abstract)

Leu SH, Chou JY, Lee PC, Cheng HC, Shao WC, Hsien WL, Huang CL, Chen VC. Validity and reliability of the Chinese version of the Sheehan Disability Scale (SDS-C). Asia Pac Psychiatry. 2015 Jun;7(2):215-22 (PubMed abstract)

Persian:
Amin-Esmaeili M, Motevalian A, Rahimi-Movaghar A, Hajebi A, Hefazi M, Radgoodarzi R, Sharifi V. The translation and psychometric assessment of the persian version of the sheehan disability scale. Iran J Psychiatry. 2014 Jul;9(3):125-32 (Full text article)

Spanish:
Luciano JV, Bertsch J, Salvador-Carulla L, Tomás JM, Fernández A, Pinto-Meza A, Haro JM, Palao DJ, Serrano-Blanco A. Factor structure, internal consistency and construct validity of the Sheehan Disability Scale in a Spanish primary care sample. J Eval Clin Pract. 2010 Oct;16(5):895-901 (PubMed abstract)

Swedish:
Soler CT, Vadlin S, Olofsdotter S, Ramklint M, Sonnby K, Nilsson K. Psychometric evaluation of the Swedish Child Sheehan Disability Scale in adolescent psychiatric patients. Scand J Child Adolesc Psychiatr Psychol. 2021 Jul 2;9:137-146 (Full text article)

E-versions

Computerized versions: Neither Dr David Sheehan nor Mapi Research Trust manage any computerized versions of the COA

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us